IL41610A - Antihypertensive compositions containing hydralazine and a 3-(1,2,5-thiadiazol-3-yloxy)-2-propanolamine derivative beta-adrenergic blocking agent - Google Patents
Antihypertensive compositions containing hydralazine and a 3-(1,2,5-thiadiazol-3-yloxy)-2-propanolamine derivative beta-adrenergic blocking agentInfo
- Publication number
- IL41610A IL41610A IL41610A IL4161073A IL41610A IL 41610 A IL41610 A IL 41610A IL 41610 A IL41610 A IL 41610A IL 4161073 A IL4161073 A IL 4161073A IL 41610 A IL41610 A IL 41610A
- Authority
- IL
- Israel
- Prior art keywords
- thiadiazol
- yloxy
- compositions containing
- blocking agent
- adrenergic blocking
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/01—Five-membered rings
- C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
- C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
- C07D285/10—1,2,5-Thiadiazoles; Hydrogenated 1,2,5-thiadiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US00232294A US3833727A (en) | 1972-03-06 | 1972-03-06 | Hydralazine and beta-adrenergic blocking agent compositions for treating hypertension |
Publications (2)
Publication Number | Publication Date |
---|---|
IL41610A0 IL41610A0 (en) | 1973-04-30 |
IL41610A true IL41610A (en) | 1975-08-31 |
Family
ID=22872572
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL41610A IL41610A (en) | 1972-03-06 | 1973-02-26 | Antihypertensive compositions containing hydralazine and a 3-(1,2,5-thiadiazol-3-yloxy)-2-propanolamine derivative beta-adrenergic blocking agent |
Country Status (19)
Country | Link |
---|---|
US (1) | US3833727A (sv) |
AT (1) | AT331966B (sv) |
BE (1) | BE796288A (sv) |
CA (1) | CA1015662A (sv) |
CY (1) | CY951A (sv) |
DD (1) | DD103559A5 (sv) |
FR (1) | FR2181786B1 (sv) |
GB (1) | GB1385648A (sv) |
HK (1) | HK23378A (sv) |
HU (1) | HU165714B (sv) |
IE (1) | IE37326B1 (sv) |
IL (1) | IL41610A (sv) |
KE (1) | KE2839A (sv) |
LU (1) | LU67144A1 (sv) |
MY (1) | MY7800295A (sv) |
NL (1) | NL176746C (sv) |
PH (1) | PH18901A (sv) |
SE (1) | SE400472B (sv) |
ZA (1) | ZA731505B (sv) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4001421A (en) * | 1971-10-27 | 1977-01-04 | Syntex (U.S.A.) Inc. | Thiazole cardiovascular agents |
NZ196227A (en) * | 1980-02-19 | 1984-09-28 | Merck & Co Inc | 1,2,5-thiadiazole derivative and ophthalmic compositions |
US4521414A (en) * | 1981-06-18 | 1985-06-04 | The Texas A&M University System | Ophthalmic compositions and their use for treating elevated intraocular pressure and glaucoma |
US20110092507A1 (en) * | 2009-10-20 | 2011-04-21 | Chin-Tsai Fan | Process for preparing R-(+)-3-morpholino-4-(3- tert-butylamino-2-hydroxypropoxy)-1,2,5-thiadiazole |
-
1972
- 1972-03-06 US US00232294A patent/US3833727A/en not_active Expired - Lifetime
-
1973
- 1973-02-26 IL IL41610A patent/IL41610A/xx unknown
- 1973-02-27 NL NLAANVRAGE7302728,A patent/NL176746C/xx not_active IP Right Cessation
- 1973-02-27 IE IE303/73A patent/IE37326B1/xx unknown
- 1973-02-27 CA CA164,752A patent/CA1015662A/en not_active Expired
- 1973-03-01 CY CY951A patent/CY951A/xx unknown
- 1973-03-01 SE SE7302895A patent/SE400472B/sv unknown
- 1973-03-01 GB GB997973A patent/GB1385648A/en not_active Expired
- 1973-03-02 LU LU67144A patent/LU67144A1/xx unknown
- 1973-03-05 HU HUME1610A patent/HU165714B/hu unknown
- 1973-03-05 BE BE128383A patent/BE796288A/xx not_active IP Right Cessation
- 1973-03-05 DD DD169223A patent/DD103559A5/xx unknown
- 1973-03-05 ZA ZA731505A patent/ZA731505B/xx unknown
- 1973-03-05 PH PH14393A patent/PH18901A/en unknown
- 1973-03-06 FR FR7307877A patent/FR2181786B1/fr not_active Expired
- 1973-03-06 AT AT195873A patent/AT331966B/de not_active IP Right Cessation
-
1978
- 1978-05-04 HK HK233/78A patent/HK23378A/xx unknown
- 1978-05-15 KE KE2839A patent/KE2839A/xx unknown
- 1978-12-30 MY MY295/78A patent/MY7800295A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
CY951A (en) | 1978-12-22 |
AU5266273A (en) | 1974-08-29 |
NL176746B (nl) | 1985-01-02 |
ZA731505B (en) | 1974-10-30 |
GB1385648A (en) | 1975-02-26 |
IE37326B1 (en) | 1977-06-22 |
KE2839A (en) | 1978-05-26 |
MY7800295A (en) | 1978-12-31 |
ATA195873A (de) | 1975-12-15 |
HK23378A (en) | 1978-05-12 |
FR2181786B1 (sv) | 1976-05-14 |
CA1015662A (en) | 1977-08-16 |
BE796288A (fr) | 1973-09-05 |
NL176746C (nl) | 1985-06-03 |
DE2310836A1 (de) | 1973-09-20 |
DD103559A5 (sv) | 1974-02-05 |
LU67144A1 (sv) | 1973-09-06 |
PH18901A (en) | 1985-10-30 |
HU165714B (sv) | 1974-10-28 |
AT331966B (de) | 1976-09-10 |
DE2310836B2 (de) | 1976-11-04 |
IE37326L (en) | 1973-09-06 |
FR2181786A1 (sv) | 1973-12-07 |
US3833727A (en) | 1974-09-03 |
NL7302728A (sv) | 1973-09-10 |
IL41610A0 (en) | 1973-04-30 |
SE400472B (sv) | 1978-04-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA733143B (en) | 2,1,3-benzothiadiazole derivatives | |
PH9682A (en) | 1,2,3,4-tetrahydro-4-phenyl-isoquinoline derivatives and pharmaceutical composition containing same | |
IL39391A (en) | 1,3,4-thiadiazol-2-yl-imidazolidinone-(2)derivatives,their preparation and herbicidal compositions containing them | |
GB1519689A (en) | 4,5-dhydro 2 - lower - alkoxycarbonylamino - 4 - phenylimidazoles and substituted phenyl derivatives thereof | |
IL51339A (en) | 3-(substituted)methylene-4-oxa-1-azabicyclo(3.2.0)heptan-7-one derivatives their preparation and pharmaceutical compositions containing them | |
PH12918A (en) | 1,3-dioxo-2-aminoalkyl-4,4-dimethyl-isoquinolines and salts thereof | |
IL48214A (en) | 2-(2,6-disubstituted-phenyl)imino)-imidazolidines,their preparation and antihypertensive compositions containing them | |
IL43840A0 (en) | New derivatives of 1,3,4-oxadiazole and fungicidal compositions containing them | |
ZA757510B (en) | 8,8-disubstituted-6-methylergolines and related compounds | |
IL41009A (en) | Antibacterial compositions containing rifamicin and a 2,4-diamino-5-benzylpyrimidine derivative | |
IL41610A (en) | Antihypertensive compositions containing hydralazine and a 3-(1,2,5-thiadiazol-3-yloxy)-2-propanolamine derivative beta-adrenergic blocking agent | |
NZ185539A (en) | Cis-4a-aryl-2-substituted-2,3,4,4a,5,6,7,7a-octa hydro-1h-2-pyrindines and pharmaceutical compositions | |
NZ184185A (en) | 3,5,5-trimethylhexanoyl-ferrocene and pharmaceutical compositions | |
IL40277A (en) | 1,3-dioxanes and herbicidal compositions containing them | |
PH11056A (en) | 3-(i-alkyl-4 or 5-nitro-2-imidazolyl)-4-imidazoline 2 thiones and compositions thereof | |
NZ185996A (en) | 6, 7-methylene-3-oxo-d-homo-17a-pregna-4, 16-dienes and pharmaceutical compositions | |
NZ182228A (en) | -1,2,4-triazol-1-yl- -alkylcarbonyl-thiophenes and fungicidal compositions | |
NZ178645A (en) | 2-amino-4-azido-6-formylamino-1,3,5-triazines and compositions | |
IL47111A (en) | 3,4-dicarboxycephalosporins and derivatives | |
ZA734103B (en) | 1,2,4-oxadiazole derivatives | |
IL38963A0 (en) | 1,4,2-dioxazine derivatives | |
NZ185290A (en) | 1,6-anhydro- -d-hexopyranose derivatives and pharmaceutical compositions | |
ZA756231B (en) | Pharmaceutical compositions comprising substituted 3-cinnamoyl-2h-pyran-2.6(3h)-diones | |
IL38791A (en) | 1,3,4,5-tetrahydro-2,3-benzoxazepine derivatives | |
IL38927A (en) | 3(5)-heteroaryl-1,2,4-triazoles,their preparation and compositions containing them |